Critical Considerations for the Design of Multi | 台灣精品獎-歷屆得獎名單
![Critical Considerations for the Design of Multi](https://i.imgur.com/DERULla.jpg)
Microphysiologicalsystems(MPS),sometimescalledorganorhuman-on-chip...Multi-organMPSaredesignedtoreplicatekeyaspectsofhumanphysiology.
![Critical Considerations for the Design of Multi](https://i.imgur.com/DERULla.jpg)
The development of new pharmaceuticals is time-intensive and expensive. A thorough assessment of a drug’s efficacy and safety must precede clinical testing in patients. Despite that rigorous evaluation, the success rate of clinical trials is low (Khalid et al., 2017[1]). Preclinical tests conducted with animal models, despite their own benefits, often fail to show the same outcomes in human trials. It has been reported that of the drugs entering human clinical trials, 30% and 58% pass phase II and phase III, respectively (Thomas et al., 2016[2]). The probability of drugs successfully moving from phase I to final approval is only about 9% (Thomas et al., 2016[3]). Upon changing the patient selection process to have “selection biomarkers” as an inclusion or exclusion criteria, the probable success rate of drugs moving from phase I to approval stage increased to about ...
Body-in-a-Cube | 台灣精品獎-歷屆得獎名單
Critical Considerations for the Design of Multi | 台灣精品獎-歷屆得獎名單
Multi | 台灣精品獎-歷屆得獎名單
Multi | 台灣精品獎-歷屆得獎名單
Multi | 台灣精品獎-歷屆得獎名單
Multi-Physiological System | 台灣精品獎-歷屆得獎名單
Multi | 台灣精品獎-歷屆得獎名單
![](https://i.imgur.com/DERULla.jpg)
109 年度台灣精品獎獲獎產品 Multi-Physiological System
由「英華達股份有限公司」生產的Multi-PhysiologicalSystem獲得109年度台灣精品獎,以下為此獎項詳細資料整理:得獎產品:Mu...